ACADIA Pharmaceuticals
(NASDAQ:ACAD)
$15.58
0.91[6.20%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$15.58
After Hours: 4:03PM EDT
Day Range14.65 - 15.5952 Wk Range12.24 - 28.06Open / Close14.75 / 15.58Float / Outstanding119.7M / 161.9M
Vol / Avg.1.3M / 1.4MMkt Cap2.5BP/E-50d Avg. Price15.97
Div / Yield-Payout Ratio-Total Float119.7MEPS-0.17

ACADIA Pharmaceuticals Stock (NASDAQ:ACAD), Quotes and News Summary

ACADIA Pharmaceuticals Stock (NASDAQ: ACAD) stock price, news, charts, stock research, profile.

Loading...
Day Range14.65 - 15.5952 Wk Range12.24 - 28.06Open / Close14.75 / 15.58Float / Outstanding119.7M / 161.9M
Vol / Avg.1.3M / 1.4MMkt Cap2.5BP/E-50d Avg. Price15.97
Div / Yield-Payout Ratio-Total Float119.7MEPS-0.17
Business Wire - Jun 17, 2022, 7:05AM
Seeking Alpha - Nov 1, 2022, 5:35PM
TalkMarkets - Oct 4, 2022, 8:52AM
Seeking Alpha - Sep 28, 2022, 8:51PM
Seeking Alpha - Aug 7, 2022, 5:35PM
Seeking Alpha - Aug 7, 2022, 5:35PM
Seeking Alpha - Aug 3, 2022, 6:08AM
Sector: Health Care.Industry: Biotechnology
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.180-0.170 0.0100
REV139.860M130.714M-9.146M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy ACADIA Pharmaceuticals (ACAD) stock?

A

You can purchase shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ACADIA Pharmaceuticals's (ACAD) competitors?

Q

What is the target price for ACADIA Pharmaceuticals (ACAD) stock?

A

The latest price target for ACADIA Pharmaceuticals (NASDAQ: ACAD) was reported by JP Morgan on Monday, November 14, 2022. The analyst firm set a price target for 17.00 expecting ACAD to rise to within 12 months (a possible 9.11% upside). 44 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ACADIA Pharmaceuticals (ACAD)?

A

The stock price for ACADIA Pharmaceuticals (NASDAQ: ACAD) is $15.58 last updated Today at November 30, 2022, 9:00 PM UTC.

Q

Does ACADIA Pharmaceuticals (ACAD) pay a dividend?

A

There are no upcoming dividends for ACADIA Pharmaceuticals.

Q

When is ACADIA Pharmaceuticals (NASDAQ:ACAD) reporting earnings?

A

ACADIA Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is ACADIA Pharmaceuticals (ACAD) going to split?

A

There is no upcoming split for ACADIA Pharmaceuticals.

Q

What sector and industry does ACADIA Pharmaceuticals (ACAD) operate in?

A

ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.